Related Experiment Video
Updated: Nov 28, 2025

08:33
Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
Published on: June 25, 2019
8.5K
Parkinson's disease and skin
Nicki Niemann1, Andrew Billnitzer2, Joseph Jankovic2
1Muhammad Ali Parkinson Center, Department of Neurology, Barrow Neurological Institute, Phoenix, AZ, USA.
Parkinsonism & Related Disorders
|November 28, 2020
Summary
Parkinson's disease (PD) is linked to various skin conditions. Studying these dermatologic disorders offers insights into PD mechanisms and potential new therapies.
Area of Science:
- Neurology
- Dermatology
- Pathophysiology
Background:
- Parkinson's disease (PD) frequently co-occurs with dermatologic conditions.
- Skin manifestations in PD patients can be broadly categorized into non-iatrogenic and iatrogenic types.
- Understanding these skin disorders may illuminate PD's underlying mechanisms.
Purpose of the Study:
- To review the spectrum of skin disorders associated with Parkinson's disease.
- To explore the role of skin in PD pathogenesis, diagnostics, and therapeutic development.
Main Methods:
- Comprehensive literature review of dermatologic conditions in Parkinson's disease patients.
- Analysis of iatrogenic and non-iatrogenic skin disorders related to PD treatments.
- Examination of recent research on alpha-synuclein in skin and stem cell therapies.
Main Results:
- Non-iatrogenic disorders include melanoma, seborrheic dermatitis, sweating abnormalities, bullous pemphigoid, and rosacea.
- Iatrogenic disorders arise from antiparkinsonian medications (e.g., carbidopa/levodopa, dopamine agonists) and delivery systems (e.g., deep brain stimulation).
- Skin fibroblasts are crucial for induced pluripotent stem cell research in PD.
Conclusions:
- The skin serves as a valuable model for studying Parkinson's disease pathogenesis.
- Skin-derived stem cells offer potential for novel PD therapies and diagnostics.
- Further research into skin manifestations can advance drug discovery for Parkinson's disease.
Related Concept Videos
Parkinson's Disease: Treatment
772
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
772
Parkinson's Disease: Overview
1.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.3K
Skin Diseases and Disorders
4.9K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
4.9K
Neural Regulation
42.3K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.3K
Changes in Skin Color: Clinical Perspectives
3.1K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
3.1K
Skin Cancer
5.4K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.4K

